Pharmacielo Ltd (PCLO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.236x

Based on the latest financial reports, Pharmacielo Ltd (PCLO) has a cash flow conversion efficiency ratio of 0.236x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-3.53 Million ≈ $-2.55 Million USD) by net assets (CA$-14.94 Million ≈ $-10.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pharmacielo Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Pharmacielo Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Pharmacielo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmacielo Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmacielo Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Complii Fintech Solutions Ltd AU:CF1	-0.119x
Mcphersons Ltd AU:MCP	0.083x
MODERN COMMERCE SA ZY-10 F:8F4	0.126x
Terragen Holdings Ltd AU:TGH	-0.330x
Jenn Feng New Energy Co Ltd TW:1538	-0.202x
eEducation Albert AB ST:ALBERT	0.534x
Rajshree Sugars & Chemicals Limited NSE:RAJSREESUG	-0.078x
Eastern International Ltd. NASDAQ:ELOG	0.025x

Annual Cash Flow Conversion Efficiency for Pharmacielo Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pharmacielo Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see PCLO market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.52 Million ≈ $-5.44 Million	CA$-1.97 Million ≈ $-1.42 Million	0.262x	-91.45%
2023-12-31	CA$-1.68 Million ≈ $-1.22 Million	CA$-5.15 Million ≈ $-3.73 Million	3.066x	+301.87%
2022-12-31	CA$6.39 Million ≈ $4.62 Million	CA$-9.71 Million ≈ $-7.02 Million	-1.519x	-46.22%
2021-12-31	CA$19.33 Million ≈ $13.98 Million	CA$-20.07 Million ≈ $-14.52 Million	-1.039x	-20.82%
2020-12-31	CA$26.25 Million ≈ $18.99 Million	CA$-22.56 Million ≈ $-16.32 Million	-0.860x	-55.33%
2019-12-31	CA$45.47 Million ≈ $32.89 Million	CA$-25.16 Million ≈ $-18.20 Million	-0.553x	-30.88%
2018-12-31	CA$185.55K ≈ $134.23K	CA$-78.47K ≈ $-56.76K	-0.423x	+98.98%
2017-12-31	CA$91.02K ≈ $65.84K	CA$-3.79 Million ≈ $-2.74 Million	-41.637x	-12744.15%
2016-12-31	CA$9.57 Million ≈ $6.92 Million	CA$-3.10 Million ≈ $-2.24 Million	-0.324x	--

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$12.24 Million

CA$16.92 Million CAD

Market Cap Rank

#26549 Global

#1093 in Canada

Share Price

CA$0.09

Change (1 day)

-14.29%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02